
Sign up to save your podcasts
Or
GLP-1 receptor agonist medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, initially developed for diabetes, offer substantial health benefits extending beyond weight loss. These "non-scale victories" include improvements in cardiovascular health, such as blood pressure and cholesterol, reduced inflammation, and better metabolic markers like blood sugar control. Patients also experience enhanced physical well-being, with increased mobility, less joint pain, and improved sleep, and report psychological benefits like increased energy and better mood, leading to a higher overall quality of life. While these medications share core mechanisms, newer dual-agonists like tirzepatide (Mounjaro/Zepbound) may provide more pronounced effects on weight and related health parameters, highlighting a holistic approach to improved health.
Read our while blog post on this topic
This is the official podcast of GLP1 Tribe
3.9
2020 ratings
GLP-1 receptor agonist medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, initially developed for diabetes, offer substantial health benefits extending beyond weight loss. These "non-scale victories" include improvements in cardiovascular health, such as blood pressure and cholesterol, reduced inflammation, and better metabolic markers like blood sugar control. Patients also experience enhanced physical well-being, with increased mobility, less joint pain, and improved sleep, and report psychological benefits like increased energy and better mood, leading to a higher overall quality of life. While these medications share core mechanisms, newer dual-agonists like tirzepatide (Mounjaro/Zepbound) may provide more pronounced effects on weight and related health parameters, highlighting a holistic approach to improved health.
Read our while blog post on this topic
This is the official podcast of GLP1 Tribe
1,097 Listeners
1,217 Listeners
634 Listeners
337 Listeners
53 Listeners
87 Listeners
1,657 Listeners
390 Listeners
94 Listeners
225 Listeners
198 Listeners
105 Listeners
291 Listeners
7 Listeners
24 Listeners